BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22012014)

  • 1. Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey.
    Pemán J; Cantón E; Linares-Sicilia MJ; Roselló EM; Borrell N; Ruiz-Pérez-de-Pipaon MT; Guinea J; García J; Porras A; García-Tapia AM; Pérez-Del-Molino L; Suárez A; Alcoba J; García-García I
    J Clin Microbiol; 2011 Dec; 49(12):4158-63. PubMed ID: 22012014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study.
    González GM; Treviño-Rangel Rde J; Palma-Nicolás JP; Martínez C; González JG; Ayala J; Caballero A; Morfín-Otero R; Rodríguez-Noriega E; Velarde F; Ascencio EP; Tinoco JC; Vázquez JA; Cano MA; León-Sicairos N; González R; Rincón J; Elías MA; Bonifaz A
    J Antimicrob Chemother; 2013 Dec; 68(12):2847-51. PubMed ID: 23869052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
    Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
    J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center.
    Marcos-Zambrano LJ; Escribano P; Sánchez C; Muñoz P; Bouza E; Guinea J
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4565-72. PubMed ID: 24867979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.
    Guinea J; Zaragoza Ó; Escribano P; Martín-Mazuelos E; Pemán J; Sánchez-Reus F; Cuenca-Estrella M;
    Antimicrob Agents Chemother; 2014; 58(3):1529-37. PubMed ID: 24366741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.
    Martí-Carrizosa M; Sánchez-Reus F; March F; Coll P
    Scand J Infect Dis; 2014 Jun; 46(6):454-61. PubMed ID: 24762093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.
    Cantón E; Pemán J; Quindós G; Eraso E; Miranda-Zapico I; Álvarez M; Merino P; Campos-Herrero I; Marco F; de la Pedrosa EG; Yagüe G; Guna R; Rubio C; Miranda C; Pazos C; Velasco D;
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5590-6. PubMed ID: 21930869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.
    Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study.
    Mokaddas EM; Al-Sweih NA; Khan ZU
    J Med Microbiol; 2007 Feb; 56(Pt 2):255-259. PubMed ID: 17244809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].
    Durán MT; Velasco D; Canle D; Moure R; Villanueva R
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
    Lindberg E; Hammarström H; Ataollahy N; Kondori N
    Sci Rep; 2019 Mar; 9(1):3838. PubMed ID: 30846717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.
    Axner-Elings M; Botero-Kleiven S; Jensen RH; Arendrup MC
    J Clin Microbiol; 2011 Jul; 49(7):2516-21. PubMed ID: 21543574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Castanheira M; Messer SA; Moet GJ; Jones RN
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):278-83. PubMed ID: 20846808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea.
    Jung SI; Shin JH; Song JH; Peck KR; Lee K; Kim MN; Chang HH; Moon CS;
    Med Mycol; 2010 Jun; 48(4):669-74. PubMed ID: 20392145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
    Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
    Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
    Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
    Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.